[1] Mehta A, Prabhakar M, Kumar P,et al. Excitotoxicity: bridge to various triggers in neurodegenerative disorders[J].Eur J Pharmacol,2013, 698(1-3):6-18. [2] 姚柱炜,张猛,周小琴, 等. 谷氨酸受体拮抗剂对电休克后抑郁大鼠记忆障碍的影响[J].医学临床研究, 2018, 35(1):675-680. [3] Zumkehr J, Rodriguez-Ortiz CJ, Cheng D, et al. Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease [J].Neurobiol Aging,2015, 36(7):2260-2271. [4] Lei M.Impairments of tight junctions are involved in D-galactose-induced brain aging [J].Neuroreport,2013, 24(12):671-676. [5] Cassano T, Pace L, Bedse G, et al. Glutamate and mitochondria: two prominent players in the oxidative stress-induced neurodegeneration[J].Curr Alzheimer Res,2016, 13(2):185-197. [6] Sonnay S, Poirot J, Just N, et al. Astrocytic and neuronal oxidative metabolism are coupled to the rate of glutamate-glutamine cycle in the tree shrew visual cortex [J].Glia,2018, 66(3):477-491. [7] Rose CF, Verkhratsky A, Parpura V. Astrocyte glutamine synthetase: pivotal in health and disease [J].Biochem Soc Trans,2013, 41(6):1518-1524. [8] Bowens NH. DCPIB, the proposed selective blocker of volume-regulated anion channels, inhibits several glutamate transport pathways in glial cells [J].Mol Pharmacol,2013, 83(1):22-32.
2019, Vol. 36 
